CLPT
ClearPoint Neuro, Inc.
NASDAQ · USHealthcareMedical - Devices
$15.05-0.66%
Price as of Jul 20, 2026
CLPT valuation
ClearPoint Neuro, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 15.12x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 23.96x
- Price / sales
- 11.11x
- Price / cash flow
- -17.55x
Enterprise value
- Enterprise value
- $479.3M
- EV / sales
- 11.80x
- EV / EBITDA
- -20.26x
- EV / EBIT
- -18.10x
- Market cap
- $451.3M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.